Lee SJ - Search Results

1

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

Hurley CK, Woolfrey A, Wang T, Haagenson M, Umejiego J, Aljurf M, Askar M, Battiwalla M, Dehn J, Horan J, Oudshoorn M, Pidala J, Saber W, Turner V, Lee SJ, Spellman SR. Hurley CK, et al. Among authors: lee sj. Blood. 2013 Jun 6;121(23):4800-6. doi: 10.1182/blood-2013-01-480343. Epub 2013 May 1. Blood. 2013. PMID: 23637130 Free PMC article.

2

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

Lee SJ, Klein JP, Barrett AJ, Ringden O, Antin JH, Cahn JY, Carabasi MH, Gale RP, Giralt S, Hale GA, Ilhan O, McCarthy PL, Socie G, Verdonck LF, Weisdorf DJ, Horowitz MM. Lee SJ, et al. Blood. 2002 Jul 15;100(2):406-14. doi: 10.1182/blood.v100.2.406. Blood. 2002. PMID: 12091329 Free article.

3

Comparison of T-cell-depleted and non-T-cell-depleted unrelated donor transplantation for hematologic diseases: clinical outcomes, quality of life, and costs.

Lee SJ, Zahrieh D, Alyea EP, Weller E, Ho VT, Antin JH, Soiffer RJ. Lee SJ, et al. Blood. 2002 Oct 15;100(8):2697-702. doi: 10.1182/blood-2002-03-0984. Blood. 2002. PMID: 12351374 Free article.

4

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation.

Antin JH, Weisdorf D, Neuberg D, Nicklow R, Clouthier S, Lee SJ, Alyea E, McGarigle C, Blazar BR, Sonis S, Soiffer RJ, Ferrara JL. Antin JH, et al. Among authors: lee sj. Blood. 2002 Nov 15;100(10):3479-82. doi: 10.1182/blood-2002-03-0985. Epub 2002 Jul 18. Blood. 2002. PMID: 12393661 Free article. Clinical Trial.

5

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation.

Antin JH, Kim HT, Cutler C, Ho VT, Lee SJ, Miklos DB, Hochberg EP, Wu CJ, Alyea EP, Soiffer RJ. Antin JH, et al. Among authors: lee sj. Blood. 2003 Sep 1;102(5):1601-5. doi: 10.1182/blood-2003-02-0489. Epub 2003 May 1. Blood. 2003. PMID: 12730113 Free article. Clinical Trial.

6

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation.

Wadleigh M, Richardson PG, Zahrieh D, Lee SJ, Cutler C, Ho V, Alyea EP, Antin JH, Stone RM, Soiffer RJ, DeAngelo DJ. Wadleigh M, et al. Among authors: lee sj. Blood. 2003 Sep 1;102(5):1578-82. doi: 10.1182/blood-2003-01-0255. Epub 2003 May 8. Blood. 2003. PMID: 12738663 Free article.

7

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study.

Marty FM, Lee SJ, Fahey MM, Alyea EP, Soiffer RJ, Antin JH, Baden LR. Marty FM, et al. Among authors: lee sj. Blood. 2003 Oct 15;102(8):2768-76. doi: 10.1182/blood-2003-01-0267. Epub 2003 Jul 10. Blood. 2003. PMID: 12855583 Free article.

8

Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Ho VT, Zahrieh D, Hochberg E, Micale E, Levin J, Reynolds C, Steckel S, Cutler C, Fisher DC, Lee SJ, Alyea EP, Ritz J, Soiffer RJ, Antin JH. Ho VT, et al. Among authors: lee sj. Blood. 2004 Aug 15;104(4):1224-6. doi: 10.1182/blood-2004-01-0028. Epub 2004 Apr 27. Blood. 2004. PMID: 15113758 Free article. Clinical Trial.

9

Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

Lee SJ, Zahrieh D, Agura E, MacMillan ML, Maziarz RT, McCarthy PL Jr, Ho VT, Cutler C, Alyea EP, Antin JH, Soiffer RJ. Lee SJ, et al. Blood. 2004 Sep 1;104(5):1559-64. doi: 10.1182/blood-2004-03-0854. Epub 2004 May 11. Blood. 2004. PMID: 15138163 Free article. Clinical Trial.

10

Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age.

Alyea EP, Kim HT, Ho V, Cutler C, Gribben J, DeAngelo DJ, Lee SJ, Windawi S, Ritz J, Stone RM, Antin JH, Soiffer RJ. Alyea EP, et al. Among authors: lee sj. Blood. 2005 Feb 15;105(4):1810-4. doi: 10.1182/blood-2004-05-1947. Epub 2004 Sep 30. Blood. 2005. PMID: 15459007 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,074 results

Search Page

Filters